1. Structure of the HRV-C 3C-Rupintrivir Complex Provides New Insights for Inhibitor Design
- Author
-
Ling Zhu, Hai Hou, Shuai Yuan, Kaiyue Fan, Yao Sun, and Zhonghao Chen
- Subjects
Models, Molecular ,0301 basic medicine ,Drug ,Phenylalanine ,media_common.quotation_subject ,030106 microbiology ,Immunology ,Biology ,Crystallography, X-Ray ,medicine.disease_cause ,Antiviral Agents ,Virus ,03 medical and health sciences ,Immune system ,Virology ,Hydrolase ,medicine ,media_common ,chemistry.chemical_classification ,Genetics ,3C Viral Proteases ,Rupintrivir ,Valine ,Isoxazoles ,Sequence Analysis, DNA ,Pyrrolidinones ,Enterovirus A, Human ,Protein Structure, Tertiary ,Amino acid ,030104 developmental biology ,Enzyme ,chemistry ,Drug Design ,Molecular Medicine ,Enterovirus ,Research Article - Abstract
Human rhinoviruses (HRVs) are the predominant infectious agents for the common cold worldwide. The HRV-C species cause severe illnesses in children and are closely related to acute exacerbations of asthma. 3C protease, a highly conserved enzyme, cleaves the viral polyprotein during replication and assists the virus in escaping the host immune system. These key roles make 3C protease an important drug target. A few structures of 3Cs complexed with an irreversible inhibitor rupintrivir have been determined. These structures shed light on the determinants of drug specificity. Here we describe the structures of HRV-C15 3C in free and inhibitor-bound forms. The volume-decreased S1’ subsite and half-closed S2 subsite, which were thought to be unique features of enterovirus A 3C proteases, appear in the HRV-C 3C protease. Rupintrivir assumes an “intermediate” conformation in the complex, which might open up additional avenues for the design of potent antiviral inhibitors. Analysis of the features of the three-dimensional structures and the amino acid sequences of 3C proteases suggest new applications for existing drugs.
- Published
- 2020
- Full Text
- View/download PDF